GlassScriptPhysician profile
Elaine Su
NPI 1073908414
$7,242.17
in general payments reported to CMS, 2019-2025
7 companies · none reported in 2025
See the full distribution for Neurology (Psychiatry & Neurology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $431 · 2020: $2,185 · 2021: $2,178 · 2022: $2,017 · 2023: $432.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $282 · Consulting Fee: $150.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $281.70 |
| Consulting Fee | $150.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genentech USA, INC. | $4,345.18 | 2019-2021 | |
| Genentech, INC. | $1,880.00 | 2022 | |
| Biogen, INC. | $277.30 | 2023 | Tysabri, Tecfidera, Tysabri |
| Horizon Therapeutics Plc | $272.32 | 2021-2023 | Uplizna |
| Alexion Pharmaceuticals, INC. | $242.89 | 2019 | |
| Novartis Pharmaceuticals Corporation | $136.86 | 2022 | |
| Emd Serono, INC. | $87.62 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Elaine Su listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.